Literature DB >> 12799788

[Hereditary spastic paraplegias].

J Finsterer1.   

Abstract

Hereditary spastic paraplegias (HSP) are characterised by symmetric spastic paraplegia, pallhypaesthesia, and urinary dysfunction (uncomplicated HSP). Complicated HSP is present if uncomplicated HSP additionally presents with epilepsy, dementia, cataract, extrapyramidal dysfunction, amyotrophy, polyneuropathy, or ichthyosis. Clinically, HSP are similar but genetically even more heterogeneous. The disease course is slowly progressive and, the earlier the disease onset, the slower the course. Causes of HSP are mutations in 20 different genes, of which eight have been identified so far. A single mutation can cause complicated and uncomplicated HSP. Onset and severity can be quite variable between both groups and within families. Despite molecular genetic advances, diagnosis of HSP still relies on clinical features and the exclusion of various differential diagnoses. Neuropathologically, there is degeneration of corticospinal, posterior column, and spinocerebellar axons. Most likely, degeneration of the longest CNS axons is due to an impaired energy supply of the anterograde and retrograde axonal transport.

Entities:  

Mesh:

Year:  2003        PMID: 12799788     DOI: 10.1007/s00115-003-1516-3

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  24 in total

Review 1.  Endocytic traffic in polarized epithelial cells: role of the actin and microtubule cytoskeleton.

Authors:  G Apodaca
Journal:  Traffic       Date:  2001-03       Impact factor: 6.215

2.  Locus-phenotype correlations in autosomal dominant pure hereditary spastic paraplegia. A clinical and molecular genetic study of 28 United Kingdom families.

Authors:  E Reid; C Grayson; M T Rogers; D C Rubinsztein
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

Review 3.  Is the transportation highway the right road for hereditary spastic paraplegia?

Authors:  Andrew H Crosby; Christos Proukakis
Journal:  Am J Hum Genet       Date:  2002-09-24       Impact factor: 11.025

4.  Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia.

Authors:  J Hazan; N Fonknechten; D Mavel; C Paternotte; D Samson; F Artiguenave; C S Davoine; C Cruaud; A Dürr; P Wincker; P Brottier; L Cattolico; V Barbe; J M Burgunder; J F Prud'homme; A Brice; B Fontaine; B Heilig; J Weissenbach
Journal:  Nat Genet       Date:  1999-11       Impact factor: 38.330

5.  Overexpression of a novel sorting nexin, SNX15, affects endosome morphology and protein trafficking.

Authors:  V A Barr; S A Phillips; S I Taylor; C R Haft
Journal:  Traffic       Date:  2000-11       Impact factor: 6.215

Review 6.  Hereditary spastic paraplegia.

Authors:  John K Fink
Journal:  Neurol Clin       Date:  2002-08       Impact factor: 3.806

7.  SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia.

Authors:  Heema Patel; Harold Cross; Christos Proukakis; Ruth Hershberger; Peer Bork; Francesca D Ciccarelli; Michael A Patton; Victor A McKusick; Andrew H Crosby
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

8.  Hereditary "pure" spastic paraplegia: a study of nine families.

Authors:  J M Polo; J Calleja; O Combarros; J Berciano
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-02       Impact factor: 10.154

9.  Novel locus for autosomal dominant pure hereditary spastic paraplegia (SPG19) maps to chromosome 9q33-q34.

Authors:  Enza Maria Valente; Francesco Brancati; Viviana Caputo; Enrico Bertini; Clarice Patrono; Danilo Costanti; Bruno Dallapiccola
Journal:  Ann Neurol       Date:  2002-06       Impact factor: 10.422

10.  Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease.

Authors:  G Casari; M De Fusco; S Ciarmatori; M Zeviani; M Mora; P Fernandez; G De Michele; A Filla; S Cocozza; R Marconi; A Dürr; B Fontaine; A Ballabio
Journal:  Cell       Date:  1998-06-12       Impact factor: 41.582

View more
  1 in total

Review 1.  [Motor neuron diseases : Clinical and genetic differential diagnostics].

Authors:  M Regensburger; N Weidner; Z Kohl
Journal:  Nervenarzt       Date:  2018-06       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.